Skip to main content

Navigation group

Type at least 3 characters
24,595 articles

Articles

Brief Research Report

Published on 28 Oct 2024

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study

in Pharmacology of Infectious Diseases

  • Rubén Martín-Escolano
  • Ana Virseda-Berdices
  • Juan Berenguer
  • Juan González-García
  • Oscar Brochado-Kith
  • Amanda Fernández-Rodríguez
  • Cristina Díez
  • Victor Hontañon
  • The Marathon Study Group
  • Salvador Resino
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1341612
  • 365 views